Acquisition by Magrath George of 5000 shares of Ocuphire Pharma at 1.7545 subject to Rule 16b-3

OCUPDelisted Stock  USD 1.13  0.06  5.04%   
Slightly above 61% of OCUP Old's investor base is looking to short. The analysis of current outlook of investing in OCUP Old suggests that many traders are alarmed regarding OCUP Old's prospects. OCUP Old's investing sentiment overview a quick insight into current market opportunities from investing in OCUP Old. Many technical investors use OCUP Old stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
  
Filed transaction by Ocuphire Pharma Officer: Chief Executive Officer. Grant, award or other acquisition pursuant to Rule 16b-3(d)

Read at macroaxis.com
Acquisition of 5000 common stock at 1.7545 of Ocuphire Pharma by Magrath George on 17th of May 2024. This event was filed by Ocuphire Pharma with SEC on 2024-05-17. Statement of changes in beneficial ownership - SEC Form 4

OCUP Old Fundamental Analysis

We analyze OCUP Old's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of OCUP Old using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of OCUP Old based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Target Price

Target Price Comparative Analysis

OCUP Old is currently under evaluation in target price category among its peers.

OCUP Old Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with OCUP Old stock to make a market-neutral strategy. Peer analysis of OCUP Old could also be used in its relative valuation, which is a method of valuing OCUP Old by comparing valuation metrics with similar companies.

Peers

OCUP Old Related Equities

EYENEyenovia   33.33   
0%
100.0%
RVPHWReviva Pharmaceuticals   25.00   
0%
75.0%
EYPTEyepoint Pharmaceuticals   6.22   
0%
18.0%
MBIOMustang Bio   4.76   
0%
14.0%
RNAZTranscode Therapeutics   3.44   
0%
10.0%
RIGLRigel Pharmaceuticals   2.95   
0%
8.0%
KODKodiak Sciences   2.68   
0%
8.0%
RVPHReviva Pharmaceuticals   1.52   
0%
4.0%
PLXProtalix Biotherapeutics   0.45   
0%
1.0%
CGTXCognition Therapeutics     
1.0%
0%
SLSSellas Life   0.94   
2.0%
0%
FBIOPFortress Biotech   4.44   
13.0%
0%
FBIOFortress Biotech   4.87   
14.0%
0%
CKPTCheckpoint Therapeutics   6.01   
18.0%
0%
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in employment.
You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.

Other Consideration for investing in OCUP Stock

If you are still planning to invest in OCUP Old check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the OCUP Old's history and understand the potential risks before investing.
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Bonds Directory
Find actively traded corporate debentures issued by US companies
Fundamental Analysis
View fundamental data based on most recent published financial statements
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios